Hester Biosciences to work with IIT-G on Covid vaccine
2020-04-30
Ahmedabad: Ahmedabad-based Hester Biosciences Limited on Wednesday announced its collaboration with Indian Institute of Technology Guwahati to work on developing a vaccine against Covid-19. The agreement was signed on April 15. The pharma major and IIT Guwahati, expect the vaccine to be ready by the end of this year to begin studies on animal. The work is currently in its early stage of development.According to the company, the vaccine will be based on recombinant avian paramyxovirus-based vector platform. “The vaccine will be based on recombinant avian paramyxovirus-based vector platform. The recombinant avian paramyxovirus-1 will be used to express the immunogenic protein of SARS-CoV-2. The recombinant avian paramyxovirus-1 expressing the SARS-CoV-2 protein could be used as a vaccine candidate for further study,” a statement issued by the city-based pharmaceutical company mentioned.Dr Sachin Kumar, associate professor of the department of biosciences and bioengineering at IIT Guwahati, said it would be too early to predict the efficacy and immunogenicity of the vaccine. Commenting on the collaboration, Rajiv Gandhi, CEO and MD, Hester Biosciences, said, “In the current pandemic situation of Covid-19, IIT-G and Hester have collaborated to develop and manufacture a recombinant vaccine against Covid-19 Hester’s involvement would be from master seed development up to release of the commercial vaccine”.